Indianapolis, Indiana — According to state and local economic development sources, Eli Lilly and Company plans to invest $20,000,000.00 to build out 32,070 square feet of new space in Indianapolis. The company plans to occupy the new space at 639 S Delaware St in Indianapolis, on or about November 1, 2023. According to the company website Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: Take what you find here and make it better and better. More than 145 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live. At Eli Lilly and Company for more than a century, we have stayed true to a core set of values: excellence, integrity, and respect for people that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and giving back to communities through philanthropy and volunteerism.

To learn more about Eli Lilly and Company, visit http://www.lilly.com/

Company Contact:
David Ricks, Chief Executive Officer
https://www.linkedin.com/in/davearicks/
800-545-5979

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.